Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE NON-CONTROLLING INTERESTS AND STOCKHOLDERS??? EQUITY

v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE NON-CONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Non-controlling Interests (“NCI”)
Redeemable non-controlling interests, beginning balance at Dec. 31, 2023 $ 46,865                  
Redeemable Non-controlling Interests (“RNCI”)                    
Distributions to RNCI (287)                  
Accretion of tax equity financing fees 54                  
Net (loss) income (2,855)                  
Redeemable non-controlling interests, ending balance at Jun. 30, 2024 43,777                  
Beginning balance (in shares) at Dec. 31, 2023       34,277,195 18,000,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2023                 2,101,795  
Beginning balance at Dec. 31, 2023 925,886     $ 3 $ 2 $ 320,892 $ 595,911 $ (3,045) $ (11,788) $ 23,911
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       62,589            
Exercise of stock options 504         504        
Stock-based compensation expense 6,704         6,704        
Employee stock purchase plan (in shares)       32,841            
Employee stock purchase plan 990         990        
Restricted stock units released (in shares)       29,890            
Unrealized gain (loss) from interest rate hedges, net 614             614    
Foreign currency translation adjustment (1,351)             (1,369)   18
Accretion of tax equity financing fees (54)           (54)      
Contributions from NCI 30,792         3,040       27,752
Distributions to NCI (1,004)                 (1,004)
Purchase of shares from NCI (23,760)         226       (23,986)
Net (loss) income 1,871           2,073     (202)
Ending balance (in shares) at Jun. 30, 2024       34,402,515 18,000,000          
Treasury stock, ending balance (in shares) at Jun. 30, 2024                 2,101,795  
Ending balance at Jun. 30, 2024 941,192     $ 3 $ 2 332,356 597,930 (3,800) $ (11,788) 26,489
Redeemable non-controlling interests, beginning balance at Mar. 31, 2024 43,908                  
Redeemable Non-controlling Interests (“RNCI”)                    
Distributions to RNCI (158)                  
Accretion of tax equity financing fees 27                  
Net (loss) income 0                  
Redeemable non-controlling interests, ending balance at Jun. 30, 2024 43,777                  
Beginning balance (in shares) at Mar. 31, 2024       34,320,161 18,000,000          
Treasury stock, beginning balance (in shares) at Mar. 31, 2024                 2,101,795  
Beginning balance at Mar. 31, 2024 930,163     $ 3 $ 2 327,367 592,947 (3,592) $ (11,788) 25,224
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       30,700            
Exercise of stock options 321         321        
Stock-based compensation expense 3,678         3,678        
Employee stock purchase plan (in shares)       32,841            
Employee stock purchase plan 990         990        
Restricted stock units released (in shares)       18,813            
Unrealized gain (loss) from interest rate hedges, net 75             75    
Foreign currency translation adjustment (189)             (283)   94
Accretion of tax equity financing fees (27)           (27)      
Contributions from NCI 1,928         0       1,928
Distributions to NCI (941)                 (941)
Net (loss) income 5,194           5,010     184
Ending balance (in shares) at Jun. 30, 2024       34,402,515 18,000,000          
Treasury stock, ending balance (in shares) at Jun. 30, 2024                 2,101,795  
Ending balance at Jun. 30, 2024 941,192     $ 3 $ 2 332,356 597,930 (3,800) $ (11,788) 26,489
Redeemable non-controlling interests, beginning balance at Dec. 31, 2024 2,463                  
Redeemable Non-controlling Interests (“RNCI”)                    
Accretion of tax equity financing fees 54                  
Net (loss) income (974)                  
Redeemable non-controlling interests, ending balance at Jun. 30, 2025 $ 1,543                  
Beginning balance (in shares) at Dec. 31, 2024   34,501,213 18,000,000 34,501,213 18,000,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 2,101,835               2,101,835  
Beginning balance at Dec. 31, 2024 $ 1,045,149     $ 3 $ 2 378,321 652,561 (5,874) $ (11,788) 31,924
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       80,178            
Exercise of stock options 503         503        
Stock-based compensation expense 6,595         6,595        
Employee stock purchase plan (in shares)       60,762            
Employee stock purchase plan 795         795        
Restricted stock units released (in shares)       61,506         0  
Unrealized gain (loss) from interest rate hedges, net (630)             (630)    
Foreign currency translation adjustment 6,679             6,744   (65)
Accretion of tax equity financing fees (54)           (54)      
Contributions from NCI 3,799         0       3,799
Distributions to NCI (2,851)                 (2,851)
Net (loss) income $ 10,886           7,381     3,505
Ending balance (in shares) at Jun. 30, 2025   34,703,659 18,000,000 34,703,659 18,000,000          
Treasury stock, ending balance (in shares) at Jun. 30, 2025 2,101,835               2,101,835  
Ending balance at Jun. 30, 2025 $ 1,070,871     $ 3 $ 2 386,214 659,888 240 $ (11,788) 36,312
Redeemable non-controlling interests, beginning balance at Mar. 31, 2025 1,966                  
Redeemable Non-controlling Interests (“RNCI”)                    
Accretion of tax equity financing fees 27                  
Net (loss) income (450)                  
Redeemable non-controlling interests, ending balance at Jun. 30, 2025 1,543                  
Beginning balance (in shares) at Mar. 31, 2025       34,603,581 18,000,000          
Treasury stock, beginning balance (in shares) at Mar. 31, 2025                 2,101,835  
Beginning balance at Mar. 31, 2025 1,046,078     $ 3 $ 2 381,595 647,051 (4,935) $ (11,788) 34,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       10,000            
Exercise of stock options 74         74        
Stock-based compensation expense 3,750         3,750        
Employee stock purchase plan (in shares)       60,762            
Employee stock purchase plan 795         795        
Restricted stock units released (in shares)       29,316            
Unrealized gain (loss) from interest rate hedges, net (128)             (128)    
Foreign currency translation adjustment 5,272             5,303   (31)
Accretion of tax equity financing fees (27)           (27)      
Contributions from NCI 938                 938
Distributions to NCI (1,849)                 (1,849)
Net (loss) income $ 15,968           12,864     3,104
Ending balance (in shares) at Jun. 30, 2025   34,703,659 18,000,000 34,703,659 18,000,000          
Treasury stock, ending balance (in shares) at Jun. 30, 2025 2,101,835               2,101,835  
Ending balance at Jun. 30, 2025 $ 1,070,871     $ 3 $ 2 $ 386,214 $ 659,888 $ 240 $ (11,788) $ 36,312